What's new in status epilepticus?

Intensive Care Medicine

Volumn 40, Issue 9, 2014, Pages 1359-1362

  Rossetti, Andrea O ^a   Bleck, Thomas P ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; HARKOSERIDE; KETAMINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ANTICONVULSIVE AGENT;

ARTIFICIAL VENTILATION; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; HUMAN; INTENSIVE CARE UNIT; KETOGENIC DIET; PROGNOSIS; REVIEW; DECISION TREE; STATUS EPILEPTICUS;

ANTICONVULSANTS; DECISION TREES; HUMANS; STATUS EPILEPTICUS;

EID: 84906938048     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3363-z     Document Type: Review

References (18)

1. Bleck TP (2005) Refractory status epilepticus. Curr Opin Crit Care 11:117-120
2. Rossetti AO, Lowenstein DH (2011) Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 10:922-930
3. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing C (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3-23
4. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348-355
5. Ferlisi M, Shorvon S (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135:2314-2328
6. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Eng J Med 366:591-600
7. Alvarez V, Januel JM, Burnand B, Rossetti AO (2011) Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 52:1292-1296
8. Yasiry Z, Shorvon SD (2014) The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 23:167-174
9. Kellinghaus C, Berning S, Stogbauer F (2014) Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand 129:294-299
10. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J (2013) The established status epilepticus trial 2013. Epilepsia 54[Suppl 6]:89-92
11. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW (2011) A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 14:4-10
12. Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Fernandez IS, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, Laroche SM (2013) Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 54:1498-1503
13. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM (2013) Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 105:183-188
14. Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, Kaplan PW, Geocadin RG, Hartman AL, Venkatesan A, Cervenka MC (2014) Ketogenic diet for adults in super-refractory status epilepticus. Neurology 82:665-670
15. Ferguson M, Bianchi MT, Sutter R, Rosenthal ES, Cash SS, Kaplan PW, Westover MB (2013) Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care 18:216-227
16. Rossetti AO, Alvarez V, Januel JM, Burnand B (2013) Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 260:421-428
17. Kowalski RG, Ziai WC, Rees RN, Werner JK Jr, Kim G, Goodwin H, Geocadin RG (2012) Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 40:2677-2684
18. Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S (2014) Anesthetic drugs in status epilepticus: risk or rescue?: A 6-year cohort study. Neurology 82:656-664